Cargando…

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study

BACKGROUND: Patients with chronic kidney disease (CKD) bear a substantial burden of comorbidities leading to the prescription of multiple drugs and a risk of polypharmacy. However, data on medication use in this population are scarce. METHODS: A total of 5217 adults with an estimated glomerular filt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Insa M, Hübner, Silvia, Nadal, Jennifer, Titze, Stephanie, Schmid, Matthias, Bärthlein, Barbara, Schlieper, Georg, Dienemann, Thomas, Schultheiss, Ulla T, Meiselbach, Heike, Köttgen, Anna, Flöge, Jürgen, Busch, Martin, Kreutz, Reinhold, Kielstein, Jan T, Eckardt, Kai-Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768303/ https://www.ncbi.nlm.nih.gov/pubmed/31584562 http://dx.doi.org/10.1093/ckj/sfz046

Ejemplares similares

Is polypharmacy an increasing burden in chronic kidney disease? The German experience
por: Parker, Kathrine, et al.
Publicado: (2019)

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
por: Schneider, Markus P., et al.
Publicado: (2018)

Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
por: Schneider, Markus P., et al.
Publicado: (2018)

Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort
por: Busch, Martin, et al.
Publicado: (2016)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease—prospective data from the German Chronic Kidney Disease cohort
por: Ruhe, Johannes, et al.
Publicado: (2023)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients
por: Lai, Silvia, et al.
Publicado: (2018)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
por: van der Vorm, Lisa N, et al.
Publicado: (2019)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
por: Lefebvre, Claire, et al.
Publicado: (2019)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

Medication discrepancies in late-stage chronic kidney disease
por: Ibrahim, Jamil, et al.
Publicado: (2018)

2017 update on pain management in patients with chronic kidney disease
por: Pham, Phuong Chi, et al.
Publicado: (2017)

Satellite cell function, intramuscular inflammation and exercise in chronic kidney disease
por: O’Sullivan, Tom F, et al.
Publicado: (2018)

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
por: Ureña-Torres, Pablo A, et al.
Publicado: (2018)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research
por: Mechta Nielsen, Trine, et al.
Publicado: (2018)

Elderly patients with chronic kidney disease: do they really need referral to the nephrology clinic?
por: McClure, Mark, et al.
Publicado: (2017)

Chronic kidney disease: considerations for monitoring skeletal muscle health and prescribing resistance exercise
por: Gollie, Jared M, et al.
Publicado: (2018)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

Small steps towards the potential of ‘preventive’ treatment of early phosphate loading in chronic kidney disease patients
por: Bover, Jordi, et al.
Publicado: (2019)

Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?
por: Cianciolo, Giuseppe, et al.
Publicado: (2017)

Cardiovascular Complications of Chronic Kidney Disease: An Introduction
por: Warrens, Hilary, et al.
Publicado: (2022)

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients
por: Fouque, Denis, et al.
Publicado: (2018)

Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2018)

Epidemiology of chronic kidney disease: think (at least) twice!
por: Delanaye, Pierre, et al.
Publicado: (2017)

Valvular Heart Disease in Patients with Chronic Kidney Disease
por: Kipourou, Konstantina, et al.
Publicado: (2022)

Management of Heart Failure in Patients with Chronic Kidney Disease
por: Ryan, David K, et al.
Publicado: (2022)

Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart–Kidney Team-Based Approach
por: Shroff, Gautam R, et al.
Publicado: (2021)

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v43ive697n7o22g8jf1ubogi0v